Anzeige
Mehr »
Lynx Broker
Login
Montag, 23.09.2019 Börsentäglich über 12.000 News von 610 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1H65A ISIN: NL0010391025 Ticker-Symbol: PHGN 
Tradegate
20.09.19
17:29 Uhr
1,300 Euro
-0,016
-1,22 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
PHARMING GROUP NV Chart 1 Jahr
5-Tage-Chart
PHARMING GROUP NV 5-Tage-Chart
RealtimeGeldBriefZeit
1,235
1,300
21.09.
1,280
1,310
20.09.

Aktuelle News zur PHARMING Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
03.09.iBio and CC-Pharming to launch plant-based rituximab in China10
27.08.iBio, CC-Pharming Expand Collaboration in China8
PHARMING Aktien ab 5,80 Euro handeln - Ohne versteckte Kosten!
26.08.iBio, Inc.: iBio and CC-Pharming Expand Business Collaboration in China13
14.08.Novartis lizenziert Produktkandidaten aus Immun-Portfolio an Pharming aus320Basel (awp) - Novartis hat seinen Produktkandidaten CDZ173 an das niederländische Unternehmen Pharming Group auslizenziert. Die Niederländer haben dafür eine Vorauszahlung von 20 Millionen US-Dollar...
► Artikel lesen
13.08.Novartis sells phase 3 rare disease drug to Pharming12
13.08.Pharming Acquires Exclusive License to CDZ173, a Late Stage Drug for the Treatment of APDS737CDZ173 is in a registration-enabling study for the treatment of APDS, an ultra-rare, debilitating disease with no approved treatment APDS is treated by immunologists; the main physicians...
► Artikel lesen
29.07.Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Kaufen101Original-Research: Pharming Group NV - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Pharming Group NV Unternehmen: Pharming Group NV ISIN:...
► Artikel lesen
28.07.Pharming Group NV (PHGUF) CEO Sijmen De Vries on Q2 2019 Results - Earnings Call Transcript3
26.07.Pharming Group Reports Strong Financial Results for the First Half of 201982Delivered 31% increase in revenue, 51% increase in operating profit and 60% increase in net profit year-on-year Delivered 21% increase in revenue, with increases in operating profit...
► Artikel lesen
25.07.Pharming Group N.V. reports 1H results15
11.06.Pharming Announces Initiation of Clinical Phase I/II Pre-Eclampsia Study59LEIDEN, Netherlands, June 11, 2019 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) today announces that, following receipt of the Dutch...
► Artikel lesen
22.05.Pharming Reports on Annual General Meeting of Shareholders82LEIDEN, Netherlands, May 22, 2019 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announces that at its Annual General Meeting of shareholders...
► Artikel lesen
21.05.Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Kaufen90Original-Research: Pharming Group NV - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Pharming Group NV Unternehmen: Pharming Group NV ISIN:...
► Artikel lesen
16.05.Pharming Today Celebrates "hae day :-)" - The Global Awareness Day for Hereditary Angioedema, a Rare Life-threatening Condition44LEIDEN, Netherlands, May 16, 2019 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) today supports world "hae day :-)". On 16 May each year...
► Artikel lesen
16.05.Pharming Group Reports Interim Financial Results for the First Quarter of 201948LEIDEN, Netherlands, May 16, 2019 /PRNewswire/ -- Main results compared to Q1 2018 19.5% increase in revenues 49% increase in operating profit ...
► Artikel lesen
10.04.Pharming Group Announces Notice to Convene to Annual General Meeting of Shareholders75LEIDEN, Netherlands, April 10, 2019 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announces that the Notice to Convene for its Annual...
► Artikel lesen
09.04.Pharming Group Announces Completion of Minority Investment in BioConnection BV50LEIDEN, The Netherlands, April 9, 2019 /PRNewswire/ -- Highlights: Pharming takes a significant minority stake in BioConnection BV, its world class fill & finish partner Pharming...
► Artikel lesen
29.03.Pharming Group Announces Publication of Its Annual Report 2018 and a Provisional Commitment to Invest in Supplier57LEIDEN, Netherlands, March 29, 2019 /PRNewswire/ -- Highlights: Annual Report 2018 is available for download on the Pharming website today at http://www.pharming.com/investors/financial-documents Printed...
► Artikel lesen
12.03.Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Kaufen79Dow Jones received a payment from EQS/DGAP to publish this press release. Original-Research: Pharming Group NV - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity...
► Artikel lesen
07.03.Pharming Group Reports Strong Preliminary Financial Results for 2018 Including First Year of Net Profit76LEIDEN, Netherlands, March 7, 2019 /PRNewswire/ -- Highlights: Full year revenues from product sales were up over 51% on 2017 to €134.3 million, reflecting strong growth...
► Artikel lesen
Seite:  Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2